1760 — Panion & BF Biotech Balance Sheet
0.000.00%
- TWD5.11bn
- TWD5.37bn
- TWD2.03bn
- 89
- 32
- 31
- 50
Annual balance sheet for Panion & BF Biotech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 349 | 464 | 535 | 558 | 460 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 363 | 361 | 359 | 401 | 422 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,275 | 1,399 | 1,477 | 1,510 | 1,467 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,524 | 1,562 | 1,635 | 1,614 | 1,693 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,953 | 3,094 | 3,235 | 3,208 | 3,227 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 740 | 922 | 1,051 | 1,027 | 1,010 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,020 | 1,086 | 1,324 | 1,286 | 1,272 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1,933 | 2,007 | 1,911 | 1,922 | 1,955 |
| Total Liabilities & Shareholders' Equity | 2,953 | 3,094 | 3,235 | 3,208 | 3,227 |
| Total Common Shares Outstanding |